{"nct_id":"NCT01978145","title":"A Non-inferiority Study to Evaluate the Efficacy, Safety, and Tolerability of Fluticasone Propionate/Salmeterol (FSC) 250/50 Microgram (mcg) Through a Capsule-Based Inhaler and a Multi-Dose Inhaler Administered Twice Daily (BID) in Adults With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","status_verified_date":"2017-07","start_date":"2013-11-14","start_date_type":"ACTUAL","primary_completion_date":"2015-04-16","primary_completion_date_type":"ACTUAL","completion_date":"2015-04-16","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}